TrueBlue - TBI Stock Forecast, Price & News

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for TrueBlue in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" TBI shares.
View TBI analyst ratings or view top-rated stocks.

2 brokerages have issued 1-year price objectives for TrueBlue's shares. Their TBI share price forecasts range from $20.00 to $21.00. On average, they anticipate the company's stock price to reach $20.50 in the next twelve months. This suggests a possible upside of 10.0% from the stock's current price.
View analysts price targets for TBI or view top-rated stocks among Wall Street analysts.

TrueBlue's stock was trading at $19.58 at the beginning of the year. Since then, TBI stock has decreased by 4.8% and is now trading at $18.64.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Monday, April 24th 2023.
View our TBI earnings forecast.

TrueBlue, Inc. (NYSE:TBI) issued its quarterly earnings data on Wednesday, February, 1st. The business services provider reported $0.43 earnings per share for the quarter, topping analysts' consensus estimates of $0.41 by $0.02. The business services provider had revenue of $557.70 million for the quarter, compared to the consensus estimate of $562.93 million. TrueBlue had a trailing twelve-month return on equity of 16.95% and a net margin of 2.76%. The business's revenue for the quarter was down 10.3% compared to the same quarter last year. During the same quarter last year, the company posted $0.69 earnings per share.

TrueBlue issued an update on its first quarter 2023 earnings guidance on Wednesday, February, 1st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $455.00 million-$480.00 million, compared to the consensus revenue estimate of $492.18 million.

34 employees have rated TrueBlue Chief Executive Officer Patrick Beharelle on Glassdoor.com. Patrick Beharelle has an approval rating of 56% among the company's employees. This puts Patrick Beharelle in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other TrueBlue investors own include International Business Machines (IBM), Intel (INTC), NVIDIA (NVDA), Vertex Pharmaceuticals (VRTX), Gilead Sciences (GILD), The Goldman Sachs Group (GS), AT&T (T), Zynga (ZNGA), AbbVie (ABBV) and Amgen (AMGN).

TrueBlue trades on the New York Stock Exchange (NYSE) under the ticker symbol "TBI."

TrueBlue's stock is owned by a number of institutional and retail investors. Top institutional investors include Pzena Investment Management LLC (6.74%), Pacer Advisors Inc. (0.94%), New York State Teachers Retirement System (0.24%), New York State Common Retirement Fund (0.16%), AE Wealth Management LLC (0.15%) and SummerHaven Investment Management LLC (0.13%). Insiders that own company stock include A Patrick Beharelle, Carl Schweihs, Colleen B Brown, Derrek Lane Gafford, Garrett Ferencz, Richard Christensen, Steven C Cooper, Taryn R Owen and William C Goings.
View institutional ownership trends.

Shares of TBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TBI stock can currently be purchased for approximately $18.64.

TrueBlue (NYSE:TBI) has a market capitalization of $609.90 million and generates $2.25 billion in revenue each year. The business services provider earns $62.27 million in net income (profit) each year or $1.86 on an earnings per share basis.

The company employs 6,400 workers across the globe.

TrueBlue's mailing address is 1015 A STREET, TACOMA WA, 98402. The official website for the company is www.trueblue.com. The business services provider can be reached via phone at (253) 383-9101, via email at investorrelations@trueblueinc.com, or via fax at 877-733-0399.